Global Oral Anti-diabetes Drugs Supply, Demand and Key Producers, 2023-2029

Description

The global Oral Anti-diabetes Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Diabetes is a chronic disease that occurs when the body cannot effectively use the produced insulin or the pancreas does not produce sufficient insulin. The pancreas is an organ that sits behind the stomach and releases hormones into the digestive system. Diabetes is categorized by increased levels of blood glucose, which can cause severe damage to blood vessels, heart, kidneys, nerves, and eyes. Diabetes is also called hyperglycemia or raised blood sugar. Insulin is a hormone that regulates the blood sugar level in body. Continuous increase in blood sugar leads to diabetes. Uncontrollable diabetes can damage the nervous system and other body systems. Diabetes is of two types: type 1 and type 2. Type 1 diabetes, also known as juvenile diabetes or insulin-dependent diabetes, arises when the immune system misguidedly attacks and kills the beta cells of the pancreas. In type 1 diabetes, little or no insulin is released into the body, owing to this sugar builds up in the blood instead of being used as energy. Type 1 diabetes is rare, and only 10% of people with diabetes have type 1 diabetes. It commonly occurs in childhood or adolescence. Type 2 diabetes arises when the body cannot appropriately use the insulin that is released or does not make enough insulin. As a consequence, sugar builds up in the blood instead of being used as energy. About 90% of people with diabetes have type 2 diabetes.

This report studies the global Oral Anti-diabetes Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oral Anti-diabetes Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Anti-diabetes Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Oral Anti-diabetes Drugs total market, 2018-2029, (USD Million)
Global Oral Anti-diabetes Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Oral Anti-diabetes Drugs total market, key domestic companies and share, (USD Million)
Global Oral Anti-diabetes Drugs revenue by player and market share 2018-2023, (USD Million)
Global Oral Anti-diabetes Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Oral Anti-diabetes Drugs total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Oral Anti-diabetes Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Eli Lilly, AstraZeneca plc, Astellas Pharma Inc, Johnson & Johnson (Janssen Pharmaceuticals), Boehringer Ingelheim, Merck, Takeda and Bristol Myers Squibb, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Anti-diabetes Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Oral Anti-diabetes Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Oral Anti-diabetes Drugs Market, Segmentation by Type
    by Type
        Liquid
        Capsule
        Tablet
    by Drug Class
        Sulfonylureas
        Meglitinides
        Biguanides
        Others

Global Oral Anti-diabetes Drugs Market, Segmentation by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

Companies Profiled:
    Sanofi
    Eli Lilly
    AstraZeneca plc
    Astellas Pharma Inc
    Johnson & Johnson (Janssen Pharmaceuticals)
    Boehringer Ingelheim
    Merck
    Takeda
    Bristol Myers Squibb
    Novartis
    Pfizer
    Abbott
    Biocon
    Sunpharma
    Novo Nordisk
    Piramal Healthcare
    Bayer Healthcare
    Dr. Reddy’s Laboratories Ltd
    Glenmark Pharmaceuticals Ltd

Key Questions Answered
1. How big is the global Oral Anti-diabetes Drugs market?
2. What is the demand of the global Oral Anti-diabetes Drugs market?
3. What is the year over year growth of the global Oral Anti-diabetes Drugs market?
4. What is the total value of the global Oral Anti-diabetes Drugs market?
5. Who are the major players in the global Oral Anti-diabetes Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Oral Anti-diabetes Drugs Introduction
    1.2 World Oral Anti-diabetes Drugs Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Oral Anti-diabetes Drugs Total Market by Region (by Headquarter Location)
        1.3.1 World Oral Anti-diabetes Drugs Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Oral Anti-diabetes Drugs Market Size (2018-2029)
        1.3.3 China Oral Anti-diabetes Drugs Market Size (2018-2029)
        1.3.4 Europe Oral Anti-diabetes Drugs Market Size (2018-2029)
        1.3.5 Japan Oral Anti-diabetes Drugs Market Size (2018-2029)
        1.3.6 South Korea Oral Anti-diabetes Drugs Market Size (2018-2029)
        1.3.7 ASEAN Oral Anti-diabetes Drugs Market Size (2018-2029)
        1.3.8 India Oral Anti-diabetes Drugs Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Oral Anti-diabetes Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Oral Anti-diabetes Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Oral Anti-diabetes Drugs Consumption Value (2018-2029)
    2.2 World Oral Anti-diabetes Drugs Consumption Value by Region
        2.2.1 World Oral Anti-diabetes Drugs Consumption Value by Region (2018-2023)
        2.2.2 World Oral Anti-diabetes Drugs Consumption Value Forecast by Region (2024-2029)
    2.3 United States Oral Anti-diabetes Drugs Consumption Value (2018-2029)
    2.4 China Oral Anti-diabetes Drugs Consumption Value (2018-2029)
    2.5 Europe Oral Anti-diabetes Drugs Consumption Value (2018-2029)
    2.6 Japan Oral Anti-diabetes Drugs Consumption Value (2018-2029)
    2.7 South Korea Oral Anti-diabetes Drugs Consumption Value (2018-2029)
    2.8 ASEAN Oral Anti-diabetes Drugs Consumption Value (2018-2029)
    2.9 India Oral Anti-diabetes Drugs Consumption Value (2018-2029)

3 World Oral Anti-diabetes Drugs Companies Competitive Analysis
    3.1 World Oral Anti-diabetes Drugs Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Oral Anti-diabetes Drugs Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Oral Anti-diabetes Drugs in 2022
        3.2.3 Global Concentration Ratios (CR8) for Oral Anti-diabetes Drugs in 2022
    3.3 Oral Anti-diabetes Drugs Company Evaluation Quadrant
    3.4 Oral Anti-diabetes Drugs Market: Overall Company Footprint Analysis
        3.4.1 Oral Anti-diabetes Drugs Market: Region Footprint
        3.4.2 Oral Anti-diabetes Drugs Market: Company Product Type Footprint
        3.4.3 Oral Anti-diabetes Drugs Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Oral Anti-diabetes Drugs Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Oral Anti-diabetes Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Oral Anti-diabetes Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Oral Anti-diabetes Drugs Consumption Value Comparison
        4.2.1 United States VS China: Oral Anti-diabetes Drugs Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Oral Anti-diabetes Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Oral Anti-diabetes Drugs Companies and Market Share, 2018-2023
        4.3.1 United States Based Oral Anti-diabetes Drugs Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Oral Anti-diabetes Drugs Revenue, (2018-2023)
    4.4 China Based Companies Oral Anti-diabetes Drugs Revenue and Market Share, 2018-2023
        4.4.1 China Based Oral Anti-diabetes Drugs Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Oral Anti-diabetes Drugs Revenue, (2018-2023)
    4.5 Rest of World Based Oral Anti-diabetes Drugs Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Oral Anti-diabetes Drugs Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Oral Anti-diabetes Drugs Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Oral Anti-diabetes Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Liquid
        5.2.2 Capsule
        5.2.3 Tablet
    5.3 Market Segment by Type
        5.3.1 World Oral Anti-diabetes Drugs Market Size by Type (2018-2023)
        5.3.2 World Oral Anti-diabetes Drugs Market Size by Type (2024-2029)
        5.3.3 World Oral Anti-diabetes Drugs Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Oral Anti-diabetes Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacies
        6.2.2 Retail Pharmacies
        6.2.3 Online Pharmacies
    6.3 Market Segment by Application
        6.3.1 World Oral Anti-diabetes Drugs Market Size by Application (2018-2023)
        6.3.2 World Oral Anti-diabetes Drugs Market Size by Application (2024-2029)
        6.3.3 World Oral Anti-diabetes Drugs Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Details
        7.1.2 Sanofi Major Business
        7.1.3 Sanofi Oral Anti-diabetes Drugs Product and Services
        7.1.4 Sanofi Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Sanofi Recent Developments/Updates
        7.1.6 Sanofi Competitive Strengths & Weaknesses
    7.2 Eli Lilly
        7.2.1 Eli Lilly Details
        7.2.2 Eli Lilly Major Business
        7.2.3 Eli Lilly Oral Anti-diabetes Drugs Product and Services
        7.2.4 Eli Lilly Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Eli Lilly Recent Developments/Updates
        7.2.6 Eli Lilly Competitive Strengths & Weaknesses
    7.3 AstraZeneca plc
        7.3.1 AstraZeneca plc Details
        7.3.2 AstraZeneca plc Major Business
        7.3.3 AstraZeneca plc Oral Anti-diabetes Drugs Product and Services
        7.3.4 AstraZeneca plc Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 AstraZeneca plc Recent Developments/Updates
        7.3.6 AstraZeneca plc Competitive Strengths & Weaknesses
    7.4 Astellas Pharma Inc
        7.4.1 Astellas Pharma Inc Details
        7.4.2 Astellas Pharma Inc Major Business
        7.4.3 Astellas Pharma Inc Oral Anti-diabetes Drugs Product and Services
        7.4.4 Astellas Pharma Inc Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Astellas Pharma Inc Recent Developments/Updates
        7.4.6 Astellas Pharma Inc Competitive Strengths & Weaknesses
    7.5 Johnson & Johnson (Janssen Pharmaceuticals)
        7.5.1 Johnson & Johnson (Janssen Pharmaceuticals) Details
        7.5.2 Johnson & Johnson (Janssen Pharmaceuticals) Major Business
        7.5.3 Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Product and Services
        7.5.4 Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Johnson & Johnson (Janssen Pharmaceuticals) Recent Developments/Updates
        7.5.6 Johnson & Johnson (Janssen Pharmaceuticals) Competitive Strengths & Weaknesses
    7.6 Boehringer Ingelheim
        7.6.1 Boehringer Ingelheim Details
        7.6.2 Boehringer Ingelheim Major Business
        7.6.3 Boehringer Ingelheim Oral Anti-diabetes Drugs Product and Services
        7.6.4 Boehringer Ingelheim Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Boehringer Ingelheim Recent Developments/Updates
        7.6.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
    7.7 Merck
        7.7.1 Merck Details
        7.7.2 Merck Major Business
        7.7.3 Merck Oral Anti-diabetes Drugs Product and Services
        7.7.4 Merck Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Merck Recent Developments/Updates
        7.7.6 Merck Competitive Strengths & Weaknesses
    7.8 Takeda
        7.8.1 Takeda Details
        7.8.2 Takeda Major Business
        7.8.3 Takeda Oral Anti-diabetes Drugs Product and Services
        7.8.4 Takeda Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Takeda Recent Developments/Updates
        7.8.6 Takeda Competitive Strengths & Weaknesses
    7.9 Bristol Myers Squibb
        7.9.1 Bristol Myers Squibb Details
        7.9.2 Bristol Myers Squibb Major Business
        7.9.3 Bristol Myers Squibb Oral Anti-diabetes Drugs Product and Services
        7.9.4 Bristol Myers Squibb Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Bristol Myers Squibb Recent Developments/Updates
        7.9.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
    7.10 Novartis
        7.10.1 Novartis Details
        7.10.2 Novartis Major Business
        7.10.3 Novartis Oral Anti-diabetes Drugs Product and Services
        7.10.4 Novartis Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Novartis Recent Developments/Updates
        7.10.6 Novartis Competitive Strengths & Weaknesses
    7.11 Pfizer
        7.11.1 Pfizer Details
        7.11.2 Pfizer Major Business
        7.11.3 Pfizer Oral Anti-diabetes Drugs Product and Services
        7.11.4 Pfizer Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Pfizer Recent Developments/Updates
        7.11.6 Pfizer Competitive Strengths & Weaknesses
    7.12 Abbott
        7.12.1 Abbott Details
        7.12.2 Abbott Major Business
        7.12.3 Abbott Oral Anti-diabetes Drugs Product and Services
        7.12.4 Abbott Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Abbott Recent Developments/Updates
        7.12.6 Abbott Competitive Strengths & Weaknesses
    7.13 Biocon
        7.13.1 Biocon Details
        7.13.2 Biocon Major Business
        7.13.3 Biocon Oral Anti-diabetes Drugs Product and Services
        7.13.4 Biocon Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Biocon Recent Developments/Updates
        7.13.6 Biocon Competitive Strengths & Weaknesses
    7.14 Sunpharma
        7.14.1 Sunpharma Details
        7.14.2 Sunpharma Major Business
        7.14.3 Sunpharma Oral Anti-diabetes Drugs Product and Services
        7.14.4 Sunpharma Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Sunpharma Recent Developments/Updates
        7.14.6 Sunpharma Competitive Strengths & Weaknesses
    7.15 Novo Nordisk
        7.15.1 Novo Nordisk Details
        7.15.2 Novo Nordisk Major Business
        7.15.3 Novo Nordisk Oral Anti-diabetes Drugs Product and Services
        7.15.4 Novo Nordisk Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Novo Nordisk Recent Developments/Updates
        7.15.6 Novo Nordisk Competitive Strengths & Weaknesses
    7.16 Piramal Healthcare
        7.16.1 Piramal Healthcare Details
        7.16.2 Piramal Healthcare Major Business
        7.16.3 Piramal Healthcare Oral Anti-diabetes Drugs Product and Services
        7.16.4 Piramal Healthcare Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 Piramal Healthcare Recent Developments/Updates
        7.16.6 Piramal Healthcare Competitive Strengths & Weaknesses
    7.17 Bayer Healthcare
        7.17.1 Bayer Healthcare Details
        7.17.2 Bayer Healthcare Major Business
        7.17.3 Bayer Healthcare Oral Anti-diabetes Drugs Product and Services
        7.17.4 Bayer Healthcare Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 Bayer Healthcare Recent Developments/Updates
        7.17.6 Bayer Healthcare Competitive Strengths & Weaknesses
    7.18 Dr. Reddy’s Laboratories Ltd
        7.18.1 Dr. Reddy’s Laboratories Ltd Details
        7.18.2 Dr. Reddy’s Laboratories Ltd Major Business
        7.18.3 Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Product and Services
        7.18.4 Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.18.5 Dr. Reddy’s Laboratories Ltd Recent Developments/Updates
        7.18.6 Dr. Reddy’s Laboratories Ltd Competitive Strengths & Weaknesses
    7.19 Glenmark Pharmaceuticals Ltd
        7.19.1 Glenmark Pharmaceuticals Ltd Details
        7.19.2 Glenmark Pharmaceuticals Ltd Major Business
        7.19.3 Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Product and Services
        7.19.4 Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.19.5 Glenmark Pharmaceuticals Ltd Recent Developments/Updates
        7.19.6 Glenmark Pharmaceuticals Ltd Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Oral Anti-diabetes Drugs Industry Chain
    8.2 Oral Anti-diabetes Drugs Upstream Analysis
    8.3 Oral Anti-diabetes Drugs Midstream Analysis
    8.4 Oral Anti-diabetes Drugs Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Oral Anti-diabetes Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Oral Anti-diabetes Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Oral Anti-diabetes Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Oral Anti-diabetes Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Oral Anti-diabetes Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Oral Anti-diabetes Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Oral Anti-diabetes Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Oral Anti-diabetes Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Oral Anti-diabetes Drugs Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Oral Anti-diabetes Drugs Players in 2022
    Table 12. World Oral Anti-diabetes Drugs Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Oral Anti-diabetes Drugs Company Evaluation Quadrant
    Table 14. Head Office of Key Oral Anti-diabetes Drugs Player
    Table 15. Oral Anti-diabetes Drugs Market: Company Product Type Footprint
    Table 16. Oral Anti-diabetes Drugs Market: Company Product Application Footprint
    Table 17. Oral Anti-diabetes Drugs Mergers & Acquisitions Activity
    Table 18. United States VS China Oral Anti-diabetes Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Oral Anti-diabetes Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Oral Anti-diabetes Drugs Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Oral Anti-diabetes Drugs Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Oral Anti-diabetes Drugs Revenue Market Share (2018-2023)
    Table 23. China Based Oral Anti-diabetes Drugs Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Oral Anti-diabetes Drugs Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Oral Anti-diabetes Drugs Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Oral Anti-diabetes Drugs Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Oral Anti-diabetes Drugs Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Oral Anti-diabetes Drugs Revenue Market Share (2018-2023)
    Table 29. World Oral Anti-diabetes Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Oral Anti-diabetes Drugs Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Oral Anti-diabetes Drugs Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Oral Anti-diabetes Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Oral Anti-diabetes Drugs Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Oral Anti-diabetes Drugs Market Size by Application (2024-2029) & (USD Million)
    Table 35. Sanofi Basic Information, Area Served and Competitors
    Table 36. Sanofi Major Business
    Table 37. Sanofi Oral Anti-diabetes Drugs Product and Services
    Table 38. Sanofi Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Sanofi Recent Developments/Updates
    Table 40. Sanofi Competitive Strengths & Weaknesses
    Table 41. Eli Lilly Basic Information, Area Served and Competitors
    Table 42. Eli Lilly Major Business
    Table 43. Eli Lilly Oral Anti-diabetes Drugs Product and Services
    Table 44. Eli Lilly Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Eli Lilly Recent Developments/Updates
    Table 46. Eli Lilly Competitive Strengths & Weaknesses
    Table 47. AstraZeneca plc Basic Information, Area Served and Competitors
    Table 48. AstraZeneca plc Major Business
    Table 49. AstraZeneca plc Oral Anti-diabetes Drugs Product and Services
    Table 50. AstraZeneca plc Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. AstraZeneca plc Recent Developments/Updates
    Table 52. AstraZeneca plc Competitive Strengths & Weaknesses
    Table 53. Astellas Pharma Inc Basic Information, Area Served and Competitors
    Table 54. Astellas Pharma Inc Major Business
    Table 55. Astellas Pharma Inc Oral Anti-diabetes Drugs Product and Services
    Table 56. Astellas Pharma Inc Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Astellas Pharma Inc Recent Developments/Updates
    Table 58. Astellas Pharma Inc Competitive Strengths & Weaknesses
    Table 59. Johnson & Johnson (Janssen Pharmaceuticals) Basic Information, Area Served and Competitors
    Table 60. Johnson & Johnson (Janssen Pharmaceuticals) Major Business
    Table 61. Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Product and Services
    Table 62. Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Johnson & Johnson (Janssen Pharmaceuticals) Recent Developments/Updates
    Table 64. Johnson & Johnson (Janssen Pharmaceuticals) Competitive Strengths & Weaknesses
    Table 65. Boehringer Ingelheim Basic Information, Area Served and Competitors
    Table 66. Boehringer Ingelheim Major Business
    Table 67. Boehringer Ingelheim Oral Anti-diabetes Drugs Product and Services
    Table 68. Boehringer Ingelheim Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Boehringer Ingelheim Recent Developments/Updates
    Table 70. Boehringer Ingelheim Competitive Strengths & Weaknesses
    Table 71. Merck Basic Information, Area Served and Competitors
    Table 72. Merck Major Business
    Table 73. Merck Oral Anti-diabetes Drugs Product and Services
    Table 74. Merck Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Merck Recent Developments/Updates
    Table 76. Merck Competitive Strengths & Weaknesses
    Table 77. Takeda Basic Information, Area Served and Competitors
    Table 78. Takeda Major Business
    Table 79. Takeda Oral Anti-diabetes Drugs Product and Services
    Table 80. Takeda Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Takeda Recent Developments/Updates
    Table 82. Takeda Competitive Strengths & Weaknesses
    Table 83. Bristol Myers Squibb Basic Information, Area Served and Competitors
    Table 84. Bristol Myers Squibb Major Business
    Table 85. Bristol Myers Squibb Oral Anti-diabetes Drugs Product and Services
    Table 86. Bristol Myers Squibb Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Bristol Myers Squibb Recent Developments/Updates
    Table 88. Bristol Myers Squibb Competitive Strengths & Weaknesses
    Table 89. Novartis Basic Information, Area Served and Competitors
    Table 90. Novartis Major Business
    Table 91. Novartis Oral Anti-diabetes Drugs Product and Services
    Table 92. Novartis Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Novartis Recent Developments/Updates
    Table 94. Novartis Competitive Strengths & Weaknesses
    Table 95. Pfizer Basic Information, Area Served and Competitors
    Table 96. Pfizer Major Business
    Table 97. Pfizer Oral Anti-diabetes Drugs Product and Services
    Table 98. Pfizer Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Pfizer Recent Developments/Updates
    Table 100. Pfizer Competitive Strengths & Weaknesses
    Table 101. Abbott Basic Information, Area Served and Competitors
    Table 102. Abbott Major Business
    Table 103. Abbott Oral Anti-diabetes Drugs Product and Services
    Table 104. Abbott Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Abbott Recent Developments/Updates
    Table 106. Abbott Competitive Strengths & Weaknesses
    Table 107. Biocon Basic Information, Area Served and Competitors
    Table 108. Biocon Major Business
    Table 109. Biocon Oral Anti-diabetes Drugs Product and Services
    Table 110. Biocon Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Biocon Recent Developments/Updates
    Table 112. Biocon Competitive Strengths & Weaknesses
    Table 113. Sunpharma Basic Information, Area Served and Competitors
    Table 114. Sunpharma Major Business
    Table 115. Sunpharma Oral Anti-diabetes Drugs Product and Services
    Table 116. Sunpharma Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Sunpharma Recent Developments/Updates
    Table 118. Sunpharma Competitive Strengths & Weaknesses
    Table 119. Novo Nordisk Basic Information, Area Served and Competitors
    Table 120. Novo Nordisk Major Business
    Table 121. Novo Nordisk Oral Anti-diabetes Drugs Product and Services
    Table 122. Novo Nordisk Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Novo Nordisk Recent Developments/Updates
    Table 124. Novo Nordisk Competitive Strengths & Weaknesses
    Table 125. Piramal Healthcare Basic Information, Area Served and Competitors
    Table 126. Piramal Healthcare Major Business
    Table 127. Piramal Healthcare Oral Anti-diabetes Drugs Product and Services
    Table 128. Piramal Healthcare Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. Piramal Healthcare Recent Developments/Updates
    Table 130. Piramal Healthcare Competitive Strengths & Weaknesses
    Table 131. Bayer Healthcare Basic Information, Area Served and Competitors
    Table 132. Bayer Healthcare Major Business
    Table 133. Bayer Healthcare Oral Anti-diabetes Drugs Product and Services
    Table 134. Bayer Healthcare Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 135. Bayer Healthcare Recent Developments/Updates
    Table 136. Bayer Healthcare Competitive Strengths & Weaknesses
    Table 137. Dr. Reddy’s Laboratories Ltd Basic Information, Area Served and Competitors
    Table 138. Dr. Reddy’s Laboratories Ltd Major Business
    Table 139. Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Product and Services
    Table 140. Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 141. Dr. Reddy’s Laboratories Ltd Recent Developments/Updates
    Table 142. Glenmark Pharmaceuticals Ltd Basic Information, Area Served and Competitors
    Table 143. Glenmark Pharmaceuticals Ltd Major Business
    Table 144. Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Product and Services
    Table 145. Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 146. Global Key Players of Oral Anti-diabetes Drugs Upstream (Raw Materials)
    Table 147. Oral Anti-diabetes Drugs Typical Customers
List of Figure
    Figure 1. Oral Anti-diabetes Drugs Picture
    Figure 2. World Oral Anti-diabetes Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Oral Anti-diabetes Drugs Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Oral Anti-diabetes Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Oral Anti-diabetes Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Oral Anti-diabetes Drugs Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Oral Anti-diabetes Drugs Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Oral Anti-diabetes Drugs Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Oral Anti-diabetes Drugs Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Oral Anti-diabetes Drugs Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Oral Anti-diabetes Drugs Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Oral Anti-diabetes Drugs Revenue (2018-2029) & (USD Million)
    Figure 13. Oral Anti-diabetes Drugs Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Oral Anti-diabetes Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Oral Anti-diabetes Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Oral Anti-diabetes Drugs by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Oral Anti-diabetes Drugs Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Oral Anti-diabetes Drugs Markets in 2022
    Figure 27. United States VS China: Oral Anti-diabetes Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Oral Anti-diabetes Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Oral Anti-diabetes Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Oral Anti-diabetes Drugs Market Size Market Share by Type in 2022
    Figure 31. Liquid
    Figure 32. Capsule
    Figure 33. Tablet
    Figure 34. World Oral Anti-diabetes Drugs Market Size Market Share by Type (2018-2029)
    Figure 35. World Oral Anti-diabetes Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Oral Anti-diabetes Drugs Market Size Market Share by Application in 2022
    Figure 37. Hospital Pharmacies
    Figure 38. Retail Pharmacies
    Figure 39. Online Pharmacies
    Figure 40. Oral Anti-diabetes Drugs Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Companies Mentioned

Sanofi
Eli Lilly
AstraZeneca plc
Astellas Pharma Inc
Johnson & Johnson (Janssen Pharmaceuticals)
Boehringer Ingelheim
Merck
Takeda
Bristol Myers Squibb
Novartis
Pfizer
Abbott
Biocon
Sunpharma
Novo Nordisk
Piramal Healthcare
Bayer Healthcare
Dr. Reddy’s Laboratories Ltd
Glenmark Pharmaceuticals Ltd